ArticleJournal of thoracic disease2018

Atezolizumab for first-line treatment of metastatic nonsquamous non-small cell lung cancer: what makes the difference?

Melissa Bersanelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.